Table 5. K-M survival analysis showed that the expression levels of the immune genes were significantly correlated with the OS and PFS in LUAD patients in the PrognoScan database.
| Gene and dataset | Prognosis | Probe ID | N | P | COX P | HR (95% CI) |
|---|---|---|---|---|---|---|
| TNFRSF11A-GSE31210 | OS | 207037_at | 204 | 0.00634647 | 0.00898712 | 2.38 (1.24–4.55) |
| TNFRSF11A-GSE31210 | OS | 238846_at | 204 | 0.168781 | 0.0472737 | 1.65 (1.01–2.72) |
| TNFRSF11A-GSE31210 | RFS | 238846_at | 204 | 0.0270956 | 0.0154956 | 1.60 (1.09–2.34) |
| TNFRSF11A-GSE31210 | RFS | 207037_at | 204 | 0.0180054 | 0.0221418 | 1.84 (1.09–3.10) |
| MS4A2-GSE31210 | OS | 207496_at | 204 | 0.00987325 | 0.00296026 | 0.54 (0.36–0.81) |
| MS4A2-GSE31210 | OS | 207497_s_at | 204 | 0.0173826 | 0.0307801 | 0.58 (0.35–0.95) |
| MS4A2-Jacob-00182-UM | OS | 207496_at | 178 | 0.086174 | 0.0336075 | 0.79 (0.63–0.98) |
| MS4A2-GSE31210 | RFS | 207496_at | 204 | 0.00155053 | 0.0032846 | 0.64 (0.48–0.86) |
| MS4A1-Jacob-00182-UM | OS | 210356_x_at | 178 | 0.259787 | 0.0342218 | 0.69 (0.49–0.97) |
| MS4A1-Jacob-00182-UM | OS | 217418_x_at | 178 | 0.168491 | 0.0421624 | 0.76 (0.59–0.99) |
| IL11-Jacob-00182-CANDF | OS | 206924_at | 82 | – | 0.0146906 | 1.96 (1.14–3.36) |
| IL11-GSE31210 | OS | 206924_at | 204 | 0.046182 | 0.248705 | 1.28 (0.84–1.95) |
| F2RL1-GSE13213 | OS | A_23_P58835 | 117 | 0.0159142 | 0.0256215 | 1.29 (1.03–1.61) |
| CAMP-MICHIGAN-LC | OS | Z38026_at | 86 | 0.00882622 | 0.207221 | 0.61 (0.28–1.32) |
K-M, Kaplan-Meier; LUAD, lung adenocarcinoma; OS, overall survival; PFS, progression-free survival.